EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. B, Biomedical sciences and applications

Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.


PMID 11393735

Abstract

Urinary metabolic ratios of caffeine are used in humans to assess the enzymatic activities of cytochrome P450 isoenzyme 1A2 (CYP1A2), xanthine oxidase (XO) and for phenotyping individuals for the bimodal N-acetyltransferase 2 (NAT2), all of them involved in the activation or detoxification of various xenobiotic compounds. Most reported analytical procedures for the measurement of the urinary metabolites of caffeine include a liquid-liquid extraction of urine samples prior to their analysis by reversed-phase HPLC. At neutral to basic pH however, 5-acetylamino-6-formylamino-3-methyluracil (AFMU), a metabolite of caffeine, spontaneously decomposes to 5-acetylamino-6-amino-3-methyluracil (AAMU). Since AAMU is not extracted in most organic solvents, the extent of AFMU decomposition cannot be precisely assessed. Although the decomposition reaction can be minimized by immediate acidification of the urine, accurate results can only be obtained when both AAMU and AFMU are monitored, or alternatively, if AAMU is measured after complete transformation of AFMU into AAMU in basic conditions. We report a liquid chromatographic method for the simultaneous quantitative analysis of the five urinary metabolites of caffeine used for the CYP1A2, XO and NAT2 phenotyping studies: AAMU, AFMU, 1-methylxanthine, 1-methyluric acid and 1,7-dimethyluric acid. These metabolites are satisfactory separated from all other known caffeine metabolites as well as endogenous urinary constituents. Sample treatment does not require any liquid-liquid extraction procedure. Urine samples are diluted and centrifuged before being injected (10 microl) onto a YMC-Pack Polyamine II (250x4.6 mm) column. A step-wise gradient elution program is applied using acetonitrile-0.75% (v/v) formic acid: (91:9) at 0 min-->(75:25) at 25 min-->(65:35) at 35 min-->(65:35) at 45 min, followed by a re-equilibration step to the initial solvent composition. The flow-rate is 1.0 ml/min and the separations are monitored by UV absorbance at 260 and 280 nm. The procedure described here represents a substantial improvement over previous methods: a single analysis and a minimal urine sample treatment enables the simultaneous quantitation of five caffeine metabolites, notably AFMU and AAMU, used for the determination of CYP450 1A2, XO and NAT2 enzyme activity. Importantly enough, phenotyping individuals for the bimodal NAT2 is made possible without the uncertainty associated with the deformylation of AFMU, which is likely to happen at all steps prior to the analysis, during sample storage and even in the bladder of the subjects.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

UC432
AAMU
C7H10N4O3
24105
Ethanol, puriss., meets analytical specification of Ph. Eur., BP, 96.0-97.2%
C2H6O
24194
Ethanol, absolute, denaturated with 0.5-1.5 Vol.% 2-butanone and approx. 0.001% Bitrex (GC), ≥98% (GC)
C2H6O
E-034
Ethanol Calibration Kit, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-040
Ethanol-10, 10 mg/dL in H2O, pack of 10 × 1.2 mL ampules, certified reference material, Cerilliant®
C2H6O
E-031
Ethanol-100 (10 ampules/kit), 100 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-038
Ethanol-100 (5 ampules/kit), 100 mg/dL in H2O, ampule of 5 × 5 mL, certified reference material, Cerilliant®
C2H6O
E-041
Ethanol-150, 150 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-056
Ethanol-20 (10 ampules/kit), 20 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-043
Ethanol-20 (5 ampules/kit), 20 mg/dL in H2O, ampule of 5 × 5 mL, certified reference material, Cerilliant®
C2H6O
E-032
Ethanol-200 (10 ampules/kit), 200 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-039
Ethanol-200 (5 ampules/kit), 200 mg/dL in H2O, ampule of 5 × 5 mL, certified reference material, Cerilliant®
C2H6O
E-035
Ethanol-25, 25 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-033
Ethanol-300, 300 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-045
Ethanol-40, 40 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-036
Ethanol-400 (10 ampules/kit), 400 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-044
Ethanol-400 (5 ampules/kit), 400 mg/dL in H2O, ampule of 5 × 5 mL, certified reference material, Cerilliant®
C2H6O
E-029
Ethanol-50, 50 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-053
Ethanol-500, 500 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-030
Ethanol-80, 80 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
C2H6O
E-037
Ethanol-80, 80 mg/dL in H2O, ampule of 5 × 5 mL, certified reference material, Cerilliant®
C2H6O
187380 Ethyl alcohol, denatured, reagent grade
459844
Ethyl alcohol, Pure, 200 proof, ACS reagent, ≥99.5%
C2H6O
E7023
Ethyl alcohol, Pure, 200 proof, for molecular biology
C2H6O
493546
Ethyl alcohol, Pure, 200 proof, meets USP testing specifications
C2H6O
459828
Ethyl alcohol, Pure, 200 proof, HPLC/spectrophotometric grade
C2H6O
E7148
Ethyl alcohol, Pure, 190 proof, for molecular biology
C2H6O
115606
Hexanal, 98%
C6H12O
W255718
Hexanal, ≥97%, FCC, FG
C6H12O
W255726
Hexanal, natural, ≥95%, FG
C6H12O